PFMU
BHC icon

Privium Fund Management (UK)’s Bausch Health BHC Stock Holding History

Privium Fund Management (UK)’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-17,500
Closed -$433K – 56
2021
Q2 		$433K Buy
+17,500
New +$530K 0.3% 43

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Privium Fund Management (UK)'s BHC Position: Q3 2021 in Review

Privium Fund Management (UK) sold out of Bausch Health (BHC) in Q3 2021, closing a stake of 17,500 shares — an estimated $433K sold.

Privium Fund Management (UK) first reported a position in BHC in Q2 2021 and held it in 1 quarter. The position peaked at $433K in Q2 2021. 346 funds tracked by Wall St. Rank hold BHC as of Q3 2021.

  • Privium Fund Management (UK) reported no remaining Bausch Health position as of Q3 2021 after selling out during the quarter.
  • Privium Fund Management (UK) sold 17,500 Bausch Health shares in Q3 2021, an estimated $433K.
  • Privium Fund Management (UK) first reported a position in Bausch Health in Q2 2021 and held it in 1 quarter.
  • Privium Fund Management (UK)'s Bausch Health position peaked at $433K in Q2 2021.
  • 346 funds tracked by Wall St. Rank held Bausch Health as of Q3 2021.

Based on Privium Fund Management (UK)'s 13F filing for Q3 2021, filed 5 Nov 2021.